NDC 82928-300 – Ekterly

Sebetralstat 300 mg/1 · Tablet · Oral

Human Prescription Drug

Product NDC82928-300

Product details

Brand name
Ekterly
Generic name
Sebetralstat
Labeler
KalVista Pharmaceuticals Ltd
Dosage form
Tablet
Route
Oral
Marketing category
NDA · NDA219301
Marketed since
July 3, 2025
Listing expires
December 31, 2027
Pharmacologic class
Plasma Kallikrein Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Ekterly →

Package NDC codes (2)

Package NDCDescriptionSince
82928-300-044 BLISTER PACK in 1 CARTON (82928-300-04) / 1 TABLET in 1 BLISTER PACK (82928-300-01)Jul 3, 2025
82928-300-052 BLISTER PACK in 1 CARTON (82928-300-05) / 2 TABLET in 1 BLISTER PACK (82928-300-02)Jul 1, 2026